Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

NCT06864936 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis (MS) - Relapsing-remitting

Interventions

DRUG: Ublituximab
OTHER: Other disease modifying therapies

Sponsor

University of Maryland, Baltimore

Collaborators

[object Object]